No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹312.8Prev. Close
₹314.25Turnover(Lac.)
₹317.82Day's High
₹319.3Day's Low
₹309.4552 Week's High
₹41952 Week's Low
₹251.95Book Value
₹63.35Face Value
₹2Mkt Cap (₹ Cr.)
3,553.56P/E
26.31EPS
12.06Divi. Yield
1.69No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 22.62 | 22.38 | 22.37 | 22.37 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 687.01 | 606.97 | 558.11 | 502.97 |
Net Worth | 709.63 | 629.35 | 580.48 | 525.34 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 272.79 | 283.47 | 247.35 | |
yoy growth (%) | -3.76 | 14.6 | ||
Raw materials | -99.2 | -96.3 | -88.75 | |
As % of sales | 36.36 | 33.97 | 35.88 | |
Employee costs | -39.31 | -34.23 | -32.6 | -32.48 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 72.07 | 98.42 | 75.85 | |
Depreciation | -9.56 | -9 | -8.81 | -7.81 |
Tax paid | -17.56 | -27.41 | -17.89 | |
Working capital | 37.28 | -10.49 | 26.58 | -6.36 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.76 | 14.6 | ||
Op profit growth | -27.86 | 31.19 | ||
EBIT growth | -26.75 | 28.03 | ||
Net profit growth | -23.23 | 22.52 | 61.47 | 3.81 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 745.76 | 636.91 | 623.87 | 540.64 | 529.38 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 745.76 | 636.91 | 623.87 | 540.64 | 529.38 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 46.19 | 33.04 | 36.66 | 25.46 | 6.42 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,941.1 | 158.19 | 4,65,710.92 | 608.7 | 0.82 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 7,248.5 | 72.26 | 1,92,375.79 | 756 | 0.41 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,961.5 | 85.26 | 1,88,654.85 | 467 | 0.68 | 2,677 | 222.76 |
Cipla Ltd CIPLA | 1,410.6 | 34.76 | 1,13,978.9 | 862.16 | 0.92 | 4,672.12 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,108.7 | 29.97 | 1,10,613.2 | 1,722 | 0.09 | 3,564.6 | 237.3 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
VASANT RATHI
E D & Wholetime Director
MUKUND MADHUSUDAN KABRA
Non-Exec & Non-Independent Dir
Rasika Rathi
Non-Exec & Non-Independent Dir
Sunny Sharma
Independent Non Exe. Director
Pramod Kasat
Independent Non Exe. Director
Vinodkumar Jajoo
Independent Non Exe. Director
NITIN JAGANNATH DESHMUKH
Independent Non Exe. Director
Vandana Tilak
Independent Director
PRADIP BHAILAL SHAH
CS / Compliance Officer / Legal Head
Sanjay Basantani
Sun Magnetica 5th Floor,
Nr LIC Serivce Road Louiswadi,
Maharashtra - 400604
Tel: 91-22-41703200
Website: http://www.advancedenzymes.com
Email: sanjay@advancedenzymes.com; info@advancedenzymes.c
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that transformed business globally in the manufacturing and sale of enzymes. The Company was incorporated, as a Private Com...
Read More
Reports by Advanced Enzyme Technologies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.